BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8796324)

  • 41. [Crystal structure of thermitase and stability of subtilisins].
    Tepliakov AV; Kuranova IP; Arutiunian EG; Frömmel C; Höhne WE
    Bioorg Khim; 1990 Apr; 16(4):437-47. PubMed ID: 2198028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protein engineering of disulfide bonds in subtilisin BPN'.
    Mitchinson C; Wells JA
    Biochemistry; 1989 May; 28(11):4807-15. PubMed ID: 2504281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a novel peptide inhibitor of subtilisin BPN'.
    Ishida K; Shimizu M; Wakasugi A; Matsui Y; Nakamura A; Kojima S
    FEBS Open Bio; 2022 Nov; 12(11):2057-2064. PubMed ID: 36053920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MD simulation of subtilisin BPN' in a crystal environment.
    Heiner AP; Berendsen HJ; van Gunsteren WF
    Proteins; 1992 Dec; 14(4):451-64. PubMed ID: 1438183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assignment of histidine resonances in the 1H NMR (500 MHz) spectrum of subtilisin BPN' using site-directed mutagenesis.
    Bycroft M; Fersht AR
    Biochemistry; 1988 Sep; 27(19):7390-4. PubMed ID: 3061456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contribution of long-range electrostatic interactions to the stabilization of the catalytic transition state of the serine protease subtilisin BPN'.
    Jackson SE; Fersht AR
    Biochemistry; 1993 Dec; 32(50):13909-16. PubMed ID: 8268166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Directed evolution of a subtilisin with calcium-independent stability.
    Strausberg SL; Alexander PA; Gallagher DT; Gilliland GL; Barnett BL; Bryan PN
    Biotechnology (N Y); 1995 Jul; 13(7):669-73. PubMed ID: 9634803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel protease inhibitors via computational redesign of subtilisin BPN' propeptide.
    Daugherty AB; Muthu P; Lutz S
    Biochemistry; 2012 Oct; 51(41):8247-55. PubMed ID: 23009354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystal structure of the complex of subtilisin BPN' with its protein inhibitor Streptomyces subtilisin inhibitor. The structure at 4.3 Angstroms resolution.
    Hirono S; Nakamura KT; Iitaka Y; Mitsui Y
    J Mol Biol; 1979 Jul; 131(4):855-69. PubMed ID: 513133
    [No Abstract]   [Full Text] [Related]  

  • 50. The crystal structure of an oxidatively stable subtilisin-like alkaline serine protease, KP-43, with a C-terminal beta-barrel domain.
    Nonaka T; Fujihashi M; Kita A; Saeki K; Ito S; Horikoshi K; Miki K
    J Biol Chem; 2004 Nov; 279(45):47344-51. PubMed ID: 15342641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of the three-dimensional structures of subtilisin BPN' and subtilisin novo.
    Drenth J; Hol WG; Jansonius JN; Koekoek R
    Cold Spring Harb Symp Quant Biol; 1972; 36():107-16. PubMed ID: 4508127
    [No Abstract]   [Full Text] [Related]  

  • 52. Stabilized variant of Streptomyces subtilisin inhibitor and its use in stabilizing subtilisin BPN'.
    Ganz PJ; Bauer MD; Sun Y; Fieno AM; Grant RA; Correa PE; Laskowski M; Saunders CW
    Protein Eng Des Sel; 2004 Apr; 17(4):333-9. PubMed ID: 15187224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. QSAR analysis of the subtilisin hydrolysis of X-phenyl hippurates. II. A study of subtilisin BPN'.
    Carotti A; Raguseo C; Klein TE; Langridge R; Hansch C
    Chem Biol Interact; 1988; 67(3-4):171-84. PubMed ID: 3056624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinetic specificities of BPN' and Carlsberg subtilisins. Mapping the aromatic binding site.
    Karasaki Y; Ohno M
    J Biochem; 1978 Sep; 84(3):531-8. PubMed ID: 102640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accelerated refolding of subtilisin BPN' by tertiary-structure-forming mutants of its propeptide.
    Kojima S; Yanai H; Miura K
    J Biochem; 2001 Oct; 130(4):471-4. PubMed ID: 11574065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Engineering a novel specificity in subtilisin BPN'.
    Rheinnecker M; Baker G; Eder J; Fersht AR
    Biochemistry; 1993 Feb; 32(5):1199-203. PubMed ID: 8448130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crystal structures of the alkaline proteases savinase and esperase from Bacillus lentus.
    Betzel C; Klupsch S; Branner S; Wilson KS
    Adv Exp Med Biol; 1996; 379():49-61. PubMed ID: 8796310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Designing substrate specificity by protein engineering of electrostatic interactions.
    Wells JA; Powers DB; Bott RR; Graycar TP; Estell DA
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1219-23. PubMed ID: 3547407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thermodynamic integration calculations of binding free energy difference for Gly-169 mutation in subtilisin BPN'.
    Wang CX; Shi YY; Zhou F; Wang L
    Proteins; 1993 Jan; 15(1):5-9. PubMed ID: 8451240
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of subtilisin BPN' and recombinant Streptomyces subtilisin inhibitors with substituted P1 site residues.
    Masuda-Momma K; Hatanaka T; Inouye K; Kanaori K; Tamura A; Akasaka K; Kojima S; Kumagai I; Miura K; Tonomura B
    J Biochem; 1993 Oct; 114(4):553-9. PubMed ID: 8276767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.